Last reviewed · How we verify

Shanchol™, oral cholera vaccine

Sachin Desai · FDA-approved active Biologic Quality 5/100

Shanchol™, oral cholera vaccine is a Biologic drug developed by Sachin Desai. It is currently FDA-approved.

Shanchol™ is an oral cholera vaccine currently on the market, developed by Sachin Desai. The key composition patent for Shanchol™ is set to expire in 2028, providing a period of exclusivity that supports its market position. The primary risk is the potential entry of generic competitors following the patent expiry in 2028.

At a glance

Generic nameShanchol™, oral cholera vaccine
SponsorSachin Desai
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Shanchol™, oral cholera vaccine

What is Shanchol™, oral cholera vaccine?

Shanchol™, oral cholera vaccine is a Biologic drug developed by Sachin Desai.

Who makes Shanchol™, oral cholera vaccine?

Shanchol™, oral cholera vaccine is developed and marketed by Sachin Desai (see full Sachin Desai pipeline at /company/sachin-desai).

What development phase is Shanchol™, oral cholera vaccine in?

Shanchol™, oral cholera vaccine is FDA-approved (marketed).

Related